We demonstrated that Akt inhibitor MK-2206 and MEK inhibitor U0126 also synergized with #43, providing a rationale for the combination of #43 with Akt/mTOR or MEK/ERK inhibitors in cancer treatment. The gene discussed is AKT1; the disease is cancer.